Flow

LOCaTION

Malmö, Sweden

Founder

Daniel Mansson, Erik Rehn

INVESTMENT Year

2021

STRATEGY

Health

When it comes to mental health, there are big shortages in the healthcare system. Since the pandemic, problems have come to the surface that have been long in need of a remedy. Healthcare providers struggle to cope with the high demand for treatment and rely largely on the prescription of antidepressants, which are fraught with severe side effects. Flow Neuroscience’s novel therapy method represents a real alternative to antidepressants and gives patients full autonomy to treat themselves. After an initial consultation with a specialist, it can be safely used at home independently as and when needed.


Visit webSite   ↗